The company highlights the features of its AI-powered Verily Me app in two 30-second spots that launched across national TV, audio and social channels. More: Verily Health simplifies medical jargon alphabet soup with AI-powered app in new campaign Source: fierce
read moreViatris and Teva Pharmaceutical Industries recently launched separate recalls related to dissolution problems for a common anxiety medication and concerns around an unapproved raw material in a high blood pressure patch, respectively. More: Viatris, Teva kick off separate recalls over
read moreThe anti-amyloid drug class has yielded some FDA approvals and plenty of failed candidates. Now, researchers are looking at the overall track record of the group and painting an unpleasant picture about the efficacy of these drugs. More: 'Absent or
read moreRather than relying on patient groups to make an impassioned plea, Roche aims to put doubts to rest around the controversial Duchenne muscular dystrophy gene therapy Elevidys with the rigor of another clinical study. More: Roche to launch another Elevidys
read moreEli Lilly is wasting no time in pursuit of the next indication for its newly christened obesity pill Foundayo, presenting new data in diabetes Thursday that also serves to address the FDA’s desire for more safety info on the oral
read moreOmnicom Health has stamped its mark on the recently acquired FCB Health New York, rebranding the ad agency as Olixir New York in the aftermath of the mega-merger with Interpublic Group. More: Omnicom brews Olixir from FCB Health, rebranding storied
read more© 1994 - 2026 B.M. Pharmaceuticals